M

Main Line Health

Biomedical research division advancing cancer science

Cardiovascular Clinical Research Coordinator 2 - Cardiovascular Clinical Research

Full-Time
No salary listed
Mid
Bachelor of Arts (BA), Bachelor of Science (BS)
Wynnewood, PA, USA
In PersonRequires periodic travel between health system hospitals.

About the job

Requirements
  • One to three or more years of experience in a hospital or clinical setting.
  • Experience in cardiology, cardiac surgery, vascular surgery, or a related medical area is preferred but not required.
  • Proficiency with Office 365, SharePoint, OneDrive, Microsoft Office tools, and website navigation.
  • Experience utilizing complex databases, electronic health record systems, and web-based data collection tools such as REDCap.
  • Strong written and verbal English-language skills.
  • A Bachelor of Arts or Bachelor of Science degree in a science-focused major is required.
  • Successful completion of CITI Program and IATA training within three months of hire is required.
Responsibilities
  • Manage a variety of device trials and support Phase II-IV drug studies.
  • Oversee and coordinate a variety of clinical studies.
  • Execute study procedures as outlined by study protocols and related documents.
  • Work under physician investigator guidance with the clinical team, hospital personnel, patients, and study sponsors.
  • Provide study coverage and manage study responsibilities across the clinical research program.
  • Travel periodically between health system hospitals.
Desired Qualifications
  • ACRP research certification is encouraged.
  • Clinical research conducted in a student environment or through past positions may be considered on a case-by-case basis.

About the company

Lankenau Institute for Medical Research (LIMR) is the research division of Main Line Health that conducts cancer and biomedical research and translates basic science into clinical applications. LIMR studies cell growth and cancer biology, develops discoveries in the lab, and collaborates to move findings into patient care within the health system. It differs from other research centers by its long history as one of the first U.S. cancer-focused institutes, its integration within a hospital-based health system, and its track record of translational research—turning lab findings into clinical therapies and practices. The institute aims to improve patient outcomes by turning basic science into usable medical treatments and interventions for cancer and related diseases.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Lancaster, Pennsylvania

Founded

1927

Get referred to Main Line Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Fitch kept Main Line Health at AA with a stable outlook on October 28, 2025.
  • June 2026 revenue reached $2.1 billion, aided by Crozer closures shifting regional demand.
  • Paoli’s June 16, 2026 expansion adds 108 beds and supports higher-acuity volume growth.

What critics are saying

  • The January 2025 200-person layoff exposed reimbursement pressure and overhead dependence.
  • The October 2025 NLRB case with Local 835 signals ongoing labor friction at Lankenau.
  • The August 2026 whistleblower lawsuit over cardiac complications threatens trust, referrals, and surgeon recruitment.

What makes Main Line Health unique

  • LIMR gives Main Line Health a rare translational research engine inside a hospital system.
  • Paoli, Lankenau, Bryn Mawr, and Riddle create a tightly integrated Philadelphia suburban network.
  • The 2026 Saint Joseph’s exclusive-provider deal expands brand visibility beyond traditional hospital care.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Pension

403(b) Retirement Plan

Unlimited Paid Time Off

Tuition Reimbursement

Wellness Program

Family Planning Benefits

Growth & Insights and Company News

Headcount

6 month growth

↑ 4%

1 year growth

↑ 4%

2 year growth

↑ 4%
PR Newswire
Nov 22nd, 2024
Independence Blue Cross Launches Epic Payer Platform To Transform Care Coordination And Boost Member Health Outcomes

PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform with health systems and providers in its network to streamline data exchange, close gaps in care, and improve health outcomes for members. Epic Payer Platform is part of Epic, a global healthcare technology company. The platform helps facilitate data exchange and workflow processes for providers and health plans, giving them the insights they need to make care decisions while also saving them time. "We're excited about the implementation of Epic Payer Platform with Drexel Medicine, Jefferson Health, Main Line Health, and Penn Medicine being the first to join us in this transformation. We look forward to more of our health care partners signing on as well," said Michael Vennera, executive vice president and chief strategy, technology, and operations officer at Independence Blue Cross

Managed Healthcare Executive
Feb 16th, 2022
Lankenau Institute For Medical Research hired George Prendergast as president and CEO on Jan 1st 04'.

When George Prendergast was appointed president and CEO of the Lankenau Institute of Medical Research (LIMR) in 2004, he coined the term “acapreneurial” as a mashup for the model he wanted to implement — inventions and startup incubation alongside traditional academic goals of research, new knowledge and its validation.